(UPDATE) Ixazomib
Selinexor
(UPDATE) Daratumumab (MM)
Elotuzumab
NCCN Guidelines for Patients: Multiple Myeloma
CancerCare
National Cancer Institute (NCI) - Supported Cancer Clinical Trials
ASCO: COVID-19 Medical Resources